Philip Jones Selected Research

Philip Jones Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 12/2006
7	Heart Failure 04/2024 - 12/2008
6	Myocardial Infarction 12/2019 - 07/2011
5	Hemorrhage 01/2021 - 02/2017
5	Infections 01/2011 - 03/2004
4	Bites and Stings (Sting) 03/2024 - 10/2019
3	Triple Negative Breast Neoplasms 04/2024 - 11/2021
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2018
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 10/2021
3	Cardiomyopathies (Cardiomyopathy) 12/2022 - 10/2005
3	Adenocarcinoma 01/2021 - 10/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 09/2008
2	Pain (Aches) 05/2023 - 04/2021
2	Dyspnea (Shortness of Breath) 01/2022 - 01/2018
2	Cognitive Dysfunction 10/2021 - 02/2006
2	Stroke (Strokes) 12/2019 - 01/2018
2	Leukemia 02/2016 - 09/2015
2	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 04/2015
1	Overactive Urinary Bladder (Overactive Bladder) 01/2023
1	Urinary Incontinence 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Consciousness Disorders 12/2022
1	Seizures (Absence Seizure) 12/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2022
1	Ketosis 01/2022
1	Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson) 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Chemotherapy-Related Cognitive Impairment 10/2021
1	Hyperalgesia 10/2021
1	Pulmonary Embolism 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 03/2024 - 09/2007
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2023 - 08/2009
6	Histones (Histone)IBA 01/2023 - 09/2007
6	Histone Deacetylases (Histone Deacetylase)IBA 06/2009 - 12/2006
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2007
4	Histone Deacetylase InhibitorsIBA 10/2008 - 12/2006
3	InterferonsIBA 03/2024 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2005
3	IACS-010759IBA 01/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 11/2021 - 05/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2016 - 11/2009
2	SodiumIBA 04/2024 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2022
2	Complementary DNA (cDNA)IBA 03/2024 - 09/2015
2	Protein Isoforms (Isoforms)IBA 03/2024 - 03/2015
2	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2022
2	Natriuretic PeptidesIBA 01/2023 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 10/2005
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2022 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2016
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 12/2012
2	C-Reactive ProteinIBA 12/2017 - 11/2017
2	Warfarin (Coumadin)FDA LinkGeneric 02/2017 - 12/2012
2	Adenosine Triphosphatases (ATPase)IBA 09/2015 - 03/2015
2	niraparibIBA 04/2015 - 11/2009
2	PyrazinesIBA 08/2011 - 08/2011
2	8a- methyl- 1,3- dioxo- 2- (2- phenylcyclopropyl)- N- (1- phenyl- 1H- pyrazol- 5- yl)hexahydroimidazo(1,5- a)pyrazine- 7(1H)- carboxamideIBA 08/2011 - 08/2011
1	CREB-Binding ProteinIBA 04/2024
1	SymportersIBA 04/2024
1	Interferon Type IIBA 03/2024
1	Opioid Analgesics (Opioids)IBA 05/2023
1	empagliflozinIBA 01/2023
1	Muscarinic AntagonistsIBA 01/2023
1	fesoterodine FDA Link 01/2023
1	Retinaldehyde (Retinal)IBA 12/2022
1	binimetinibIBA 09/2022
1	palbociclibIBA 09/2022
1	acylcarnitineIBA 01/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022
1	dapagliflozinIBA 01/2022
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 12/2021
1	ClaudinsIBA 12/2021
1	Mitogen-Activated Protein KinasesIBA 10/2021
1	compound 30IBA 10/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021
1	PlatinumIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Glutamine (L-Glutamine)FDA Link 11/2020
1	osimertinibIBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020

Therapy/Procedure

25	Therapeutics 02/2024 - 12/2006
5	Length of Stay 05/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2023 - 07/2011
4	Percutaneous Coronary Intervention 12/2019 - 02/2017
3	Immunotherapy 01/2021 - 01/2011
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2022 - 12/2019
2	Catheters 01/2021 - 11/2014
2	Blood Transfusion (Blood Transfusions) 12/2019 - 01/2018
2	Drug-Eluting Stents 01/2019 - 02/2017
2	Renal Dialysis (Hemodialysis) 01/2018 - 06/2005
1	Liver Transplantation 12/2022
1	Neoadjuvant Therapy 11/2021
1	Patient Readmission 01/2021